We are USCAST
and we help healthcare providers use the safest and most respiratory quinolones ciprofloxacin effective antibiotics to treat patient infections.
is to help establish crucial standards for testing the bacteria-killing power of antibiotics. The results we interpret and share, allow healthcare providers to use the safest and most effective tools to save patient lives.
The USCAST organization is pleased to announce that the latest version (v1.2) of the Quinolone In Vitro Susceptibility Test Interpretive Criteria Evaluations is now available!
The USCAST organization is pleased to announce the final version release (v3.0) of the USCAST Interpretive Tables.
The USCAST organization is pleased to announce the final version release (v3.0) of the USCAST Comparison Tables.
USCAST Surrogate Testing Guidance document is now available!
Breakpoint tables for interpretation of MICs and zone diameters (v2.1) are now available!
The USCAST organization is pleased to announce the “Quinolone In Vitro Susceptibility Test Interpretation Criteria Evaluation" report is now available!
Updated Breakpoint Tables Comparing USCAST, EUCAST, CLSI and USA-FDA now available!
News & Events
Final agenda available for our 2017 Annual Open ciprofloxacin Public Meeting. Click here to view...
USCAST announces its 2017 Annual Open Public Meeting. Learn more...
USCAST was cited in recent publications
In 2017 USCAST is releasing several new breakpoint documents.
Check back monthly for the latest updates!
- Polymyxin Class Breakpoints (Colistin)
- Cephalosporin Breakpoints (Ceftaroline, Ceftazidime-Avibactam and Ceftolozane-Tazobactam)
- Tetracycline Class Breakpoints (Doxycycline, Minocycline, Tetracycline, Tigecycline)
USCAST is a proud associate of EUCAST
Cached Shigella treatment ciprofloxacin dosage Asian fake LEGO reviewed - Asmyldof
Cipralex 10 mg-Filmtabletten
Ciprofloxacin (Cipro) for UTI: Dosage, How Long It Takes to Works